DDrare: Database of Drug Development for Rare Diseases

Cf patients with a g551d mutation and treated with ivacaftor (DrugBank: Ivacaftor)

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02194881 (ClinicalTrials.gov)	October 2014	17/7/2014	Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation	Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation - Efficacy and Safety Results After the First Year of Treatment in the Real Life Setting.	Cystic Fibrosis	Drug: CF patients with a G551D mutation and treated with Ivacaftor	Assistance Publique - Hôpitaux de Paris	Vaincre la Mucoviscidose	Completed	6 Years	N/A	All	57	N/A	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02194881
(ClinicalTrials.gov)

October 2014

17/7/2014

Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation

Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation - Efficacy and Safety Results After the First Year of Treatment in the Real Life Setting.

Cystic Fibrosis

Drug: CF patients with a G551D mutation and treated with Ivacaftor

Assistance Publique - Hôpitaux de Paris

Vaincre la Mucoviscidose

Completed

6 Years

N/A

All

N/A

France